Forum Energy's 15min MACD Death Cross, Bearish Marubozu Signal Triggered

The 15-minute chart for Forum Energy recently exhibited a MACD Death Cross, accompanied by a Bearish Marubozu at 10:45 AM on October 17, 2025. This technical indicator suggests that the stock price has the potential to continue its downward trajectory, with sellers dominating the market and bearish momentum likely to persist.

Uranium Royalty Corp. (NASDAQ: UROY) experienced a significant surge in its stock price this week, reaching a new 52-week high — the stock touched ~$4.87 intraday before settling around $4.75, with UROY hitting a new high. This upward movement comes on the heels of a broader uranium rally, with shares jumping ~11% in the past day and over 85% year-on-year. The stock's performance is closely tied to the uranium market, which has seen prices hit their highest levels in over a decade, recently topping $80 per pound.

The global nuclear energy revival is projected to double uranium demand by the 2030s, fueling investor enthusiasm for uranium-related equities like UROY. The company's latest earnings report also surprised to the upside, with revenue of $28.9 million last quarter, beating expectations of ~$9.5 million and posting a profit of $0.01 EPS. This marked UROY's first profitable quarter, with C$33.16 million revenue and C$1.53 million net income in Q1 2025.

Wall Street is mixed on UROY, with a consensus "Hold" rating and a price target around $4.50. Raymond James downgraded UROY to Market Perform after its run-up, raising its target to C$5.00 but citing valuation concerns. However, the firm praised UROY's high-margin, diversified model and strong balance sheet as a "lower-risk" uranium play.

Options traders have shown strong bullish sentiment, with call options volume leaping 1,590% above average as the stock rallied. UROY's unique positioning as the only pure-play uranium royalty company further supports its stock performance. The company holds royalties and physical uranium interests across dozens of projects in Canada, the U.S., and Namibia, providing leveraged exposure to uranium prices without operational mining risks.

The stock's recent performance is driven by several factors, including uranium commodity prices breaking multi-year records, bullish sector news, and UROY's own positive developments. The company's inclusion in the S&P/TSX Global Mining Index in late September also contributed to the stock's rise. UROY's earnings turnaround, with revenue over triple expectations and a net profit of C$1.53 million, has further bolstered investor confidence.

Despite the positive momentum, analysts are debating how much of the uranium boom is already priced into UROY's stock. While some analysts upgraded their stance and raised price targets, others remain cautious about the stock's valuation. Raymond James, for instance, downgraded UROY's rating from "Outperform" to "Market Perform" after the stock's huge run-up.

UROY's stock has been on a tear, doubling in value over the past year and surging ~85% year-to-date. The company's strong balance sheet, with no long-term debt and a high current ratio, further supports its investment case. The combination of a diversified asset base, strategic sales of physical uranium inventory, and a focus on scaling the royalty portfolio positions UROY well for long-term growth as the nuclear resurgence unfolds.